The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Nivolumab plus cisplatin/pemetrexed or cisplatin/gemcitabine as induction in resectable NSCLC.
 
Nathaniel R. Evans
No Relationships to Disclose
 
Scott Cowan
No Relationships to Disclose
 
Charalambos Solomides
No Relationships to Disclose
 
D. Craig Hooper
Employment - Galderma (I)
Stock and Other Ownership Interests - ImageMoverMD
Consulting or Advisory Role - Bio-Path Holdings, Inc
Research Funding - Bio-Path Holdings, Inc (Inst); ImageMoverMD (Inst)
Patents, Royalties, Other Intellectual Property - Royalties from patents issued in my name but entirely controlled by, and licensed by Thomas Jefferson University. All payments are from Thomas Jefferson University.
Travel, Accommodations, Expenses - ImageMoverMD
 
Larry Harshyne
No Relationships to Disclose
 
Grace L. Lu-Yao
No Relationships to Disclose
 
Hushan Yang
No Relationships to Disclose
 
Linda Phan
No Relationships to Disclose
 
Dawn Poller
No Relationships to Disclose
 
Benjamin Leiby
Consulting or Advisory Role - Bayer
 
Maria Werner-Wasik
Stock and Other Ownership Interests - Illumina (I)
Research Funding - Elekta
Patents, Royalties, Other Intellectual Property - signal transduction inhibitor in lymphoma (I)
 
Bo Lu
No Relationships to Disclose
 
Jennifer Maria Johnson
No Relationships to Disclose
 
Rita Susan Axelrod
No Relationships to Disclose
 
Athanassios Argiris
Consulting or Advisory Role - Bristol-Myers Squibb; Debiopharm Group; Merck Serono; Roche
Speakers' Bureau - Bristol-Myers Squibb; Merck Serono
Research Funding - Bristol-Myers Squibb; Genentech/Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Serono
 
Ralph Zinner
Employment - Merck (I)
Stock and Other Ownership Interests - Merck (I)
Research Funding - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Lilly; Merck (I)